Medical Policy Update Bulletin Quick View : March 2026
A quick-view bulletin listing recently approved, updated, revised, replaced, or retired UnitedHealthcare medical policies and medical benefit drug policies with effective dates. It notifies providers of policy status changes and directs readers to full policies for details.
Category III Codes status updated effective 2026-04-01.
Embolization of the Ovarian and Iliac Veins for Pelvic Congestion Syndrome status updated effective 2026-03-01.
Lower Extremity Endovascular Procedures status updated effective 2026-03-01.
Lower Extremity Endovascular Procedures clinical criteria revised effective 2026-05-01.
Preventive Care Services revised effective 2026-04-01.
Spinal Fusion and Decompression revised effective 2026-04-01.
Surgery of the Hip status updated effective 2026-03-01.
Surgery of the Knee status updated effective 2026-03-01.
Treatment of Temporomandibular Joint Disorders revised effective 2026-03-01.
Vertebral Body Tethering for Scoliosis revised effective 2026-04-01.
Complement C5 Inhibitors drug policy revised effective 2026-04-01.
Denosumab drug policy revised effective 2026-04-01.
Evkeeza (Evinacumab-Dgnb) drug policy updated effective 2026-04-01.
FcRn Blockers drug policy revised effective 2026-04-01.
Oncology Medication Clinical Coverage revised effective 2026-04-01.
Ophthalmologic VEGF Inhibitors drug policy revised effective 2026-04-01.
Provider Administered Drugs - Site of Care policy revised effective 2026-04-01.
Respiratory Interleukins (Cinqair, Fasenra, & Nucala) status updated effective 2026-04-01.
Somatostatin Analogs drug policy revised effective 2026-04-01.
Uplizna (Inebilizumab-Cdon) drug policy revised effective 2026-04-01.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.